TW200720248A - Crystal or hydrate of magnesium mono-allyl malonate - Google Patents
Crystal or hydrate of magnesium mono-allyl malonateInfo
- Publication number
- TW200720248A TW200720248A TW095116811A TW95116811A TW200720248A TW 200720248 A TW200720248 A TW 200720248A TW 095116811 A TW095116811 A TW 095116811A TW 95116811 A TW95116811 A TW 95116811A TW 200720248 A TW200720248 A TW 200720248A
- Authority
- TW
- Taiwan
- Prior art keywords
- hydrate
- crystal
- allyl malonate
- magnesium mono
- mono
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
- C07C69/38—Malonic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005140895A JP2008214192A (ja) | 2005-05-13 | 2005-05-13 | モノアリルマロネートマグネシウム塩の結晶 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200720248A true TW200720248A (en) | 2007-06-01 |
Family
ID=37396602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095116811A TW200720248A (en) | 2005-05-13 | 2006-05-12 | Crystal or hydrate of magnesium mono-allyl malonate |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2008214192A (zh) |
TW (1) | TW200720248A (zh) |
WO (1) | WO2006121094A1 (zh) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4870199A (en) * | 1986-04-30 | 1989-09-26 | Sandoz Pharm. Corp. | Processes for the synthesis of diprotected R[R*,S*]-3,5-dihydroxy-6-oxohexanoate esters |
JP4694370B2 (ja) * | 2002-10-18 | 2011-06-08 | 明治製菓株式会社 | マロン酸モノエステルおよびその製造方法 |
-
2005
- 2005-05-13 JP JP2005140895A patent/JP2008214192A/ja active Pending
-
2006
- 2006-05-11 WO PCT/JP2006/309444 patent/WO2006121094A1/ja active Application Filing
- 2006-05-12 TW TW095116811A patent/TW200720248A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2006121094A1 (ja) | 2006-11-16 |
JP2008214192A (ja) | 2008-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010014836A3 (en) | Tgr5 modulators and methods of use thereof | |
SG171617A1 (en) | Therapeutic compounds | |
EP1953151A4 (en) | SALTS FROM A CYNNAMIDE COMPOUND OR SOLVATE THEREOF | |
EP1908757A4 (en) | CHOLIN SALT CRYSTAL OF AN AZULAR COMPOUND | |
PT1761520E (pt) | Inibidores de quinase | |
JO2947B1 (en) | Compounds corresponding to cyclopamine | |
TW200640924A (en) | VEGF-R2 inhibitors and methods | |
WO2007105058A8 (en) | Pyrazole compounds | |
CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
EP1973682A4 (en) | SYNTHESIS OF DISPERSIONS OF METALLIC NANOPARTICLES | |
MX2010002902A (es) | Pirimidinas anti-infecciosas y usos de las mismas. | |
EP1933694A4 (en) | EYE TRACKING DEVICE HAVING EXTENDED SCOPE OF OPERATING DISTANCES | |
HK1083341A1 (en) | Stable crystal of 4-oxoquinoline compound | |
HK1168096A1 (en) | 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis | |
SI1860098T1 (sl) | Nov derivat antranilne kisline ali sol le-tega | |
TW200716543A (en) | Chemical compounds VII | |
DOP2005000010A (es) | Inhibidores de quinasa | |
IL196656A0 (en) | Sulfonamide compound or salt thereof | |
TW200728310A (en) | Process for the preparation of ferri-succinylcasein | |
WO2008053334A3 (en) | An improved process for preparing rosuvastatin calcium | |
HUE050540T2 (hu) | (R)-5-((E)-2-pirrolidin-3-ilvinil)pirimidin elõállítása és új sóformái | |
EP1951393A4 (en) | REACTION COKRISTALLIZATION OF MOLECULAR COMPLEX OR COCISTLE | |
MX2008011666A (es) | Sintesis de compuestos que modulan la actividad de la trombopoyetina. | |
IL200087A0 (en) | Novel crystal of piperacillin sodium | |
TW200726746A (en) | Processes for production of 4-biphenylylazetidin-2-ones |